Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Testosterone Drugs Raise Heart Risk in $1 Billion Market
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Submitted by
admin
on November 6, 2013 - 8:34am
Source:
Bloomberg
News Tags:
testosterone
Eli Lilly
Actavis
Androgel
Axiron
AbbVie
Androderm
Headline:
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Do Not Allow Advertisers to Use My Personal information
